Abstract
Introduction
Rhabdomyosarcoma is the most common soft tissue sarcoma of childhood and adolescence. It arises from the embryonic muscles tissue or the pluripotential mesenchyme. It is a malignant skeletal muscle tumour and histologically it resembles the normal foetal skeletal muscle before innervation. The benign variant, rhabdomyoma, is very rare.
There are four histological types -embryonic, alveolar, botryoidal and pleomorphic 1. Approximately 60% of all newly diagnosed rhabdomyosarcomas are of embryonal type, and usually happen in younger children. The alveolar type is less common and found in older children.
Rhabdomyosarcoma accounts for about 60 % of all sarcomas in the paediatric population and 4-8 % of all paediatric cancers. Nearly half of these tumours occur in children under the age of 5. Males are affected 1.5 times more often than females. 2 40% of all Rhabdomyosarcoma occur in the head and neck region. It can also involve the extremities and genitourinary tract. It arises in three main head and neck sites 1 -orbit, parameningeal sites (nasopharynx, nasal fossa, para-nasal sinuses, infra-temporal fossa, ptrygoid fossa, middle ear and mastoid) and non-parameningeal sites (scalp, face, parotid, oral cavity, oropharynx, larynx and neck).
Those arising at parameningeal sites have an affinity to invade the cranial cavity via basal skull foramina and are consequently associated with the worst prognosis.
Nasal or paranasal rhabdomyosarcoma may present with a gradual onset of nasal obstruction and bloody nasal discharge. Tumours within the ear may present with symptoms of bloody discharge and persistent otalgia, despite treatment. A polypoid mass may be visible in the ear canal or nasal cavity. The swelling was tender and warm. Serosanguinous discharge came out from the ear canal on pressing over the swelling.
A biopsy from the protruding aural mass was already taken before his admission; histopathology report revealed the mass to be an Embryonal Rhabdomyosarcoma.
A CT scan of the Head-Neck region was done, which showed the extension of the mass into the temporal and infra-temporal fossa and in the mastoid antrum. The tumor pressed over the base of the skull but it didn't penetrate into the brain.
During surgery, an extended post-auricular incision was given, starting from 3 cm behind the pinna, went vertically downwards and then extended slightly forward into the neck. The facial nerve was intimately incorporated into the mass and had to be sacrificed for proper clearance.
The mass obtained through surgery also revealed to be Embryonal rhabdomyosarcoma on histopathology.
Postoperative chemotherapy schedule comprised of bolus doses of Vincristine and Dactinomycine for 9-12 cycles, which was prescribed by the oncology deptt.
Discussion
Assessment of such a case should include a thorough examination of the upper respiratory tract and head and neck region including the cranial nerves. Flexible nasoendoscopy may be employed in the clinic.
Diagnosis is usually confirmed on biopsy and histopathology. MRI is used to evaluate the primary lesion and to rule out metastatic disease. CT scan may be a useful to determine bony erosion of the skull base and it is the best method to assess the chest for metastasis. In cases of parameningeal rhabdomyosarcoma a cytological examination of CSF may be needed.
There are three commonly used staging systems for rhabdomyosarcoma: Surgicopathologic criteria including local extension, regional and distant metastases are used to stage rhabdomyosarcoma. When the specific site of origin is incorporated into the TNM staging system as it correlates well with the outcome.
Since the establishment of the IRS (Intergroup Rhabdomyosarcoma Study) Committee in 1972, a multi-modality approach has been adopted in the management of rhabdomyosarcoma. Surgery followed by combination chemotherapy with or without adjuvant radiotherapy is commonly used as primary treatment for rhabdomyosarcoma.
Complete surgical excision remains a critical component of treatment for rhabdomyosarcoma, however radical surgery is frequently not possible due to close proximity of the tumours to vital structures and also due to the possibility of significant postoperative cosmetic and functional morbidity.
The prognosis for this tumour used to be extremely poor (approximately 10 % of patients survived five years) but over the last 30 years survival rates have increased dramatically (over 80 %), (4) particularly with the introduction of multi-modality therapy in which surgery, multi-agent chemotherapy and radiotherapy have been combined. With more advanced tumours the prognosis is still relatively poor and in those with meningeal involvement the five-year survival is less than 10 %. Younger patients tend to have a more favourable prognosis, for unknown reasons
Conclusion
Although rare in general, the incidence of rhabdomyosarcoma isn't insignificant in the paediatric age group. Its propensity to invade the cranial cavity along with the metastatic potential makes it a troublesome clinical entity to deal with. Otolaryngologists need to be aware of this condition as initially the tumor may mimic the symptoms of CSOM or nasal polyp, which may sometimes misguide them. So proper preoperative evaluation, peroperative assessment with complete resection, Post-operative chemoradiation, and long term followup is the mainstay of management of this condition.
